Advertisement

Topics

Sorafenib Offers Survival Improvements in Ovarian Cancer

06:25 EDT 15 Sep 2018 | Cancer Networks

Sorafenib combined with topotecan and then continued as maintenance therapy offered a significant improvement in survival outcomes in women with platinum-resistant ovarian cancer.

Original Article: Sorafenib Offers Survival Improvements in Ovarian Cancer

NEXT ARTICLE

More From BioPortfolio on "Sorafenib Offers Survival Improvements in Ovarian Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...